StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

AnaptysBio's pe ratio was 7.5× on Oct 19, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20267.5×−61.3
2022Jan 31, 202268.8×−6.0
2021Dec 31, 202174.7×–

More AnaptysBio figures

See a number that looks wrong?